Standout Papers

Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque 2020 2026 2022 2024335
  1. Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque (2020)
    Zsófia D. Drobni, Raza M. Alvi et al. Circulation

Immediate Impact

1 from Science/Nature 66 standout
Sub-graph 1 of 23

Citing Papers

Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications
2025 Standout
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
2025 Standout
1 intermediate paper

Works of Hannah Gilman being referenced

Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines
2022
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque
2020 Standout

Author Peers

Author Last Decade Papers Cites
Hannah Gilman 449 360 62 140 20 736
Sarah Hartmann 394 334 57 120 8 649
Marcella Occelli 340 220 52 173 28 670
Rümeysa Çiftçi 376 129 68 240 43 754
Anne‐Flore Plane 459 167 46 166 12 629
Yat Yin Lam 308 526 67 127 15 672
Kenzo Sugi 117 326 26 70 12 767
Adam Corken 289 110 17 108 15 725
Leslie Oleksowicz 228 95 31 93 35 760
Leticia Esparza 341 67 20 170 25 780
Jean Bernard Durand 335 323 73 96 16 633

All Works

Loading papers...

Rankless by CCL
2026